Our Cancer Care program has received national accreditation with commendations from the Commission on Cancer. Read more >
First-class cancer care, close to home.
Dealing with cancer can be a tough journey. But it doesn’t have to take you far from home. Whether you’re concerned about your risk factors for cancer, or are looking for comprehensive resources to combat this disease on all fronts, Day Kimball Healthcare offers the high-quality care and treatments you need — without the added stress of long and tiring commutes.
We provide compassionate, first-class cancer care right here in Northeast Connecticut. Our integrated approach brings together the services and expertise of physicians, cancer specialists, certified oncology nurses, a dedicated oncology nurse navigator and social worker, and an extended team of other professionals who all work together to ensure you have the best possible care and quality of life, so you can concentrate on getting well.
Our integrated Cancer Care services include:
Risk Prevention Assessment/Genetic Testing
We work hard to confront cancer well before any diagnosis of this challenging disease. To that end, your Day Kimball primary care physician offers a wide variety of risk prevention assessments, including clinical breast exams, bone density tests, prostate cancer screenings, colonoscopies and genetic testing for those with a high-risk family history of cancer. Learn more…
When you receive a cancer diagnosis, it can be overwhelming. Our oncology nurse navigator is there to help coordinate your hematology/oncology treatments and assist you in accessing diagnostic imaging services, surgical care, nutritional consultations and physical medicine and rehabilitation services as necessary, as well as financial assistance resources, support groups, and social services. Learn more…
Our caring and skilled certified oncology nurses, working in concert with our associated esteemed physicians from Eastern Connecticut Hematology and Oncology Associates, provide outpatient and inpatient chemotherapy, biotherapy, transfusions, iron infusions and injections at our Rose Bove LaRose Cancer Center at Day Kimball Hospital. Participation in clinical trials is available as well. Learn more…
Our surgical team works collaboratively with your nurse navigator and the rest of your cancer care team to provide the highest level of surgical and follow-up care to fight your cancer on all fronts. Learn more…
Emotional support is critical when you’re fighting cancer. That’s why we complement our medical cancer care by hosting or connecting you with a variety of support groups and programs, including a general Cancer Support Group, Breast Cancer Support Group, and our Look Good Feel Better ® group for breast cancer patients, as well as a Caregiver Support Group, local Relay for Life events and classes to help you quit smoking. Learn more…
Northeast Connecticut Cancer Fund of DKH
The Northeast Connecticut community graciously and generously supports our Northeast Connecticut Cancer Fund, which provides financial assistance for cancer-related screening and treatment services to those in need. Learn more…
We believe that every patient has a right to:
- A specific diagnosis within a week of a suspicious biopsy
- A prompt appointment with an oncologist with whom he or she feels comfortable, when referred by a primary care practitioner, surgeon or other specialist for evaluation of suspected cancer
- A second opinion
- A copy of medical records, including pathology report
- Information about condition and treatment options in language the patient can understand
- Knowledge of the scientific evidence behind the doctor's treatment recommendation, and the strength of that evidence
- Information about the benefits and risks of a particular treatment, including the benefits and risks of not having the treatment
- Information about clinical trials
Public Reporting of Outcomes
As an accredited cancer care program by the Commission on Cancer, Day Kimball Hospital reports annually on the patient experience and outcomes at our Cancer Center for particular cancers. These reports are below.
2016: Non-Hodgkin Lymphoma
2015: Non-Small Cell Lung Cancer